EV miR-192
EV miR-192 has been studied in 1 paper since 2020: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Sep 1, 2020: “Aging-Associated Extracellular Vesicles Contain Immune Regulatory microRNAs Alleviating Hyperinflammatory State and Immune Dysfunction in the Elderly”.
1 paper studies it3 findingsUpdated
See all 1 papers on EV miR-192
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Government of Japan Ministry of Education Culture Sports Science and Technology and 8 more
- Animals1
What did studies of EV miR-192 find?
3Studies of EV miR-192 measured 3 outcomes: influenza vaccination efficacy, prolonged lung inflammation and inflammation in macrophages.
Influenza vaccination efficacy
upin mice1
1 study
Influenza vaccination efficacy
upin mice1
EV miR-192 improves influenza vaccination efficacy in mice (aged mice with hyperinflammatory state).
“EV miR-192 attenuated this hyperinflammatory state and improved vaccination efficacy in aged mice.”
Animalsaged mice with hyperinflammatory stateextracellular vesicle-associated
iScience
prolonged lung inflammation
downin mice1
1 study
prolonged lung inflammation
downin mice1
EV miR-192 decreases prolonged lung inflammation in mice (aged mice stimulated with inactivated influenza whole virus particles).
“EV miR-192 alleviated the prolonged inflammation associated with aging.”
Animalsaged mice stimulated with inactivated influenza whole virus particlesextracellular vesicle-associatedlung
iScience
inflammation in macrophages
downin mouse cells1
1 study
inflammation in macrophages
downin mouse cells1
EV miR-192 decreases inflammation in macrophages in mouse cells.
“EV miR-192 exhibited anti-inflammatory effects on macrophages.”
Cellsextracellular vesicle-associatedmacrophage
iScience